- Presentations
- 2
- Markets
- 1
Admelog is a brand of Insulin lispro marketed by Sanofi-Aventis, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Insulin lispro
- Brand owner
- Sanofi-Aventis
- Registered in
- United States
- Strengths and forms
- 100 units/mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Admelog 100 units/mL injectionIntravenous, subcutaneous Cold chain | Sanofi-Aventis | US FDA | Available on request |
| Admelog 100 units/mL injectionSubcutaneous Cold chain | Sanofi-Aventis | US FDA | Available on request |
Equivalent brands
Other brands of Insulin lispro.
Humalog KwikPenEli LillyLYUMJEV KwikPenEli LillyLyumjevEli LillyHumalogEli LillyHumalog Junior KwikPenEli LillyHumalog Mix50/50 KwikPenEli LillyHumalog Mix75/25Eli LillyHumalog Mix75/25 KwikPenEli LillyHumalog Tempo PenEli LillyInsulin Lispro Junior KwikPenEli LillyInsulin Lispro KwikPenEli LillyInsulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPenEli LillyLYUMJEV Junior KwikPenEli LillyLYUMJEV Tempo PenEli Lilly
Brand names and trademarks belong to their owners and are used only to identify products.
Request Admelog
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.